153 related articles for article (PubMed ID: 24730441)
1. Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis.
Santos NP; Oliveira PA; Arantes-Rodrigues R; Faustino-Rocha AI; Colaço A; Lopes C; Gil da Costa RM
Int J Exp Pathol; 2014 Jun; 95(3):191-8. PubMed ID: 24730441
[TBL] [Abstract][Full Text] [Related]
2. The N-nitrosodiethylamine mouse model: sketching a timeline of evolution of chemically-induced hepatic lesions.
Da Costa RM; Paula-Santos N; Rocha AF; Colaço A; Lopes C; Oliveira PA
Anticancer Res; 2014 Dec; 34(12):7029-37. PubMed ID: 25503129
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
4. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
5. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis.
Pok S; Wen V; Shackel N; Alsop A; Pyakurel P; Fahrer A; Farrell GC; Teoh NC
J Gastroenterol Hepatol; 2013 Sep; 28(9):1545-54. PubMed ID: 23574010
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Bruckmann A; Hoering M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905933
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
Shibuya M; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
[TBL] [Abstract][Full Text] [Related]
9. Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice.
Kushida M; Kamendulis LM; Peat TJ; Klaunig JE
Toxicol Pathol; 2011 Aug; 39(5):776-86. PubMed ID: 21628716
[TBL] [Abstract][Full Text] [Related]
10. Constitutive Notch2 signaling induces hepatic tumors in mice.
Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
[TBL] [Abstract][Full Text] [Related]
11. Histology, bioenergetics and oxidative stress in mouse liver exposed to N-diethylnitrosamine.
Santos NP; Pereira IC; Pires MJ; Lopes C; Andrade R; Oliveira MM; Colaço A; Peixoto F; Oliveira PA
In Vivo; 2012; 26(6):921-9. PubMed ID: 23160673
[TBL] [Abstract][Full Text] [Related]
12. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
13. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment.
Mu X; Español-Suñer R; Mederacke I; Affò S; Manco R; Sempoux C; Lemaigre FP; Adili A; Yuan D; Weber A; Unger K; Heikenwälder M; Leclercq IA; Schwabe RF
J Clin Invest; 2015 Oct; 125(10):3891-903. PubMed ID: 26348897
[TBL] [Abstract][Full Text] [Related]
16. Transplanted bone marrow stromal cells are not cellular origin of hepatocellular carcinomas in a mouse model of carcinogenesis.
Zheng JF; Liang LJ
World J Gastroenterol; 2008 May; 14(19):3015-20. PubMed ID: 18494052
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 8/18 is a useful immunohistochemical marker for hepatocellular proliferative lesions in mice.
Kawai M; Saegusa Y; Kemmochi S; Harada T; Shimamoto K; Shibutani M; Mitsumori K
J Vet Med Sci; 2010 Mar; 72(3):263-9. PubMed ID: 20035116
[TBL] [Abstract][Full Text] [Related]
18. Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
Goldfarb S; Pugh TD; Koen H; He YZ
Environ Health Perspect; 1983 Apr; 50():149-61. PubMed ID: 6873010
[TBL] [Abstract][Full Text] [Related]
19. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
Tamano S; Merlino GT; Ward JM
Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats.
Bralet MP; Pichard V; Ferry N
Hepatology; 2002 Sep; 36(3):623-30. PubMed ID: 12198654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
